Endocrinology of the stress response.

The stress response is subserved by the stress system, which is located both in the central nervous system and the periphery. The principal effectors of the stress system include corticotropin-releasing hormone (CRH); arginine vasopressin; the proopiomelanocortin-derived peptides alpha-melanocyte-stimulating hormone and beta-endorphin, the glucocorticoids; and the catecholamines norepinephrine and epinephrine. Appropriate responsiveness of the stress system to stressors is a crucial prerequisite for a sense of well-being, adequate performance of tasks, and positive social interactions. By contrast, inappropriate responsiveness of the stress system may impair growth and development and may account for a number of endocrine, metabolic, autoimmune, and psychiatric disorders. The development and severity of these conditions primarily depend on the genetic vulnerability of the individual, the exposure to adverse environmental factors, and the timing of the stressful events, given that prenatal life, infancy, childhood, and adolescence are critical periods characterized by increased vulnerability to stressors.

[1]  P. Deuster,et al.  Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1β (IL-1β), IL-6, and Tumor Necrosis Factor-α (TNFα) Production in Humans: High Sensitivity of TNFα and Resistance of IL-6 , 1997 .

[2]  D. Boumpas,et al.  Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.

[3]  J. Calabrese,et al.  Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. , 1986, The New England journal of medicine.

[4]  D. Matthews,et al.  Reversibility of physiological growth hormone secretion in children with psychosocial dwarfism , 1994 .

[5]  G. Chrousos,et al.  Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. , 1987, The Journal of clinical endocrinology and metabolism.

[6]  G. Bray,et al.  Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. , 1991, The American journal of physiology.

[7]  G. Chrousos,et al.  Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Young,et al.  Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis. , 1993, The Journal of clinical endocrinology and metabolism.

[9]  Y. Taché,et al.  Interleukin 1β inhibits gastric emptying in rats: Mediation through prostaglandin and corticotropin-releasing factor , 1994 .

[10]  G. Chrousos,et al.  Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro , 1988, Brain Research.

[11]  G. Chrousos,et al.  Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. , 1998, Endocrinology.

[12]  G. Chrousos The Future of Pediatric and Adolescent Endocrinology , 1997, Annals of the New York Academy of Sciences.

[13]  M. Palkovits,et al.  Decreased central and peripheral catecholaminergic activation in obese Zucker rats. , 1995, Endocrinology.

[14]  I. Clarke,et al.  Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement , 1994, The Journal of clinical investigation.

[15]  G. Kingsley,et al.  Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.

[16]  G. Chrousos,et al.  Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. , 1994, Endocrine reviews.

[17]  P. J. Larsen,et al.  Substance P Inhibits the Release of Anterior Pituitary Adrenocorticotrophin via a Central Mechanism Involving Corticotrophin‐Releasing Factor‐Containing Neurons in the Hypothalamic Paraventricular Nucleus , 1993, Journal of neuroendocrinology.

[18]  G. Chrousos,et al.  Interactions between the Hypothalamic-Pituitary-Adrenal Axis and the Female Reproductive System: Clinical Implications , 1998, Annals of Internal Medicine.

[19]  M. Meaney,et al.  The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  G. Chrousos,et al.  Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Pasquali,et al.  The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. , 1993, The Journal of clinical endocrinology and metabolism.

[22]  O. Cameron,et al.  Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. , 1991, Archives of general psychiatry.

[23]  T. Gray 3 – Amygdala: Role in Autonomic and Neuroendocrine Responses to Stress , 1991 .

[24]  I. Heuser,et al.  Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse , 1989, Psychoneuroendocrinology.

[25]  B. Chipps,et al.  Reduction of serum testosterone levels during chronic glucocorticoid therapy. , 1986, Annals of internal medicine.

[26]  S. Suomi,et al.  Early stress and adult emotional reactivity in rhesus monkeys. , 1991, Ciba Foundation symposium.

[27]  G. Chrousos,et al.  Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. , 1996, The Journal of clinical endocrinology and metabolism.

[28]  G. Chrousos,et al.  Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease , 1999, Trends in Endocrinology & Metabolism.

[29]  T. H. Holmes,et al.  Life change and onset of illness. , 1977, The Medical clinics of North America.

[30]  T. Bouchard,et al.  Genes, environment, and personality. , 1994, Science.

[31]  U. Ehlert,et al.  Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus–pituitary–adrenal axis , 2001, Biological Psychology.

[32]  T. Pedrazzini,et al.  Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism , 2001, Molecular and Cellular Endocrinology.

[33]  F. Mora,et al.  Involvement of α- and β-adrenoreceptors in the central action of norepinephrine on temperature, metabolism, heart and respiratory rates of the conscious primate , 1983, Brain Research Bulletin.

[34]  G. Aguilera,et al.  Participation of alpha 1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress. , 1992, Neuroendocrinology.

[35]  G. Chrousos,et al.  In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. , 1996, Endocrinology.

[36]  G. Chrousos,et al.  Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. , 1990, Endocrinology.

[37]  G. Chrousos The role of stress and the hypothalamic–pituitary–adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes , 2000, International Journal of Obesity.

[38]  A Barkan,et al.  Decreased hypothalamic gonadotropin-releasing hormone secretion in male marathon runners. , 1986, The New England journal of medicine.

[39]  J. Norton,et al.  Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery. , 1992, Metabolism: clinical and experimental.

[40]  G. Chrousos Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective. , 1992, Endocrinology and metabolism clinics of North America.

[41]  G. Aghajanian,et al.  alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. , 1982, Science.

[42]  T. Begenisich,et al.  Regulation of fluid and electrolyte secretion in salivary gland acinar cells. , 2005, Annual review of physiology.

[43]  D. London,et al.  PATTERNS OF ACTH AND CORTISOL PULSATILITY OVER TWENTY‐FOUR HOURS IN NORMAL MALES AND FEMALES , 1990, Clinical endocrinology.

[44]  G. Chrousos,et al.  The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.

[45]  G. Benker,et al.  Tsh Secretion In Cushing's Syndrome: Relation To Glucocorticoid Excess, Diabetes, Goitre, And The ‘Sick Euthyroid Syndrome’ , 1990, Clinical endocrinology.

[46]  K. Malik,et al.  Neuropeptide Y inhibits adrenergic transmitter release in cultured rat superior cervical ganglion cells by restricting the availability of calcium through a pertussis toxin-sensitive mechanism , 1994, Neuroscience.

[47]  R. Roth,et al.  Stress and the Mesocorticolimbic Dopamine Systems a , 1988, Annals of the New York Academy of Sciences.

[48]  R. Fuller Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats , 1995, Behavioural Brain Research.

[49]  R. Bonsall,et al.  Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. , 2000, JAMA.

[50]  G. Chrousos,et al.  Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists , 2002, Trends in Endocrinology & Metabolism.

[51]  Paul Ky,et al.  Neuroendocrine signals in the regulation of gonadotropin-releasing hormone secretion. , 1997 .

[52]  B. Burguera,et al.  Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. , 1990, Neuroendocrinology.

[53]  B. Jeanrenaud,et al.  CNS-periphery relationships and body weight homeostasis: influence of the glucocorticoid status , 2000, International Journal of Obesity.

[54]  G. Chrousos,et al.  Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. , 1994, The Journal of clinical endocrinology and metabolism.

[55]  W. P. Chen,et al.  Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus. , 1989, Neuroendocrinology.

[56]  G. Chrousos,et al.  Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. , 2001, The Journal of endocrinology.

[57]  L. Aarden,et al.  The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. , 1990, Clinical immunology and immunopathology.

[58]  G. Chrousos,et al.  Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states , 2002, Molecular Psychiatry.

[59]  J. Ottenweller,et al.  Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. , 1982, Endocrinology.

[60]  P. Hindmarsh,et al.  Direct effects of corticotrophin‐releasing hormone on stimulated growth hormone secretion , 1998, Clinical endocrinology.

[61]  A Luger,et al.  Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. , 1987, The New England journal of medicine.

[62]  G. Chrousos,et al.  Basic and clinical studies with corticotropin-releasing hormone. Implications for a possible role in panic disorder. , 1988, The Psychiatric clinics of North America.

[63]  A. Imperato,et al.  Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis , 1991, Brain Research.

[64]  G. Chrousos,et al.  Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. , 1993, The Journal of clinical endocrinology and metabolism.

[65]  G. Chrousos,et al.  Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. , 1988, The Journal of clinical investigation.

[66]  G. Chrousos,et al.  Transcriptional and Translational Regulation of the Splicing Isoforms of the Growth Hormone Receptor by Glucocorticoids , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[67]  G. Gillies,et al.  Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin , 1982, Nature.

[68]  M. Owen,et al.  The genetic basis of complex human behaviors. , 1994, Science.

[69]  K. Catt,et al.  Magnocellular axons in passage through the median eminence release vasopressin , 1986, Nature.

[70]  G. Chrousos,et al.  Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. , 1988, The Journal of clinical investigation.

[71]  G. Chrousos,et al.  THE HYPOTHALAMIC‐PITUITARY‐ADRENAL AXIS IN INFANTILE MALNUTRITION , 1990, Clinical endocrinology.

[72]  C. Tsigos,et al.  Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. , 1994, Endocrinology and metabolism clinics of North America.

[73]  G. Chrousos,et al.  The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.

[74]  G. Chrousos,et al.  Neuroendocrinology of stress. , 2001, Endocrinology and metabolism clinics of North America.

[75]  D. Skuse,et al.  A new stress-related syndrome of growth failure and hyperphagia in children, associated with reversibility of growth-hormone insufficiency , 1996, The Lancet.

[76]  G. Chrousos,et al.  Final stature in patients with endogenous Cushing's syndrome. , 1994, The Journal of clinical endocrinology and metabolism.

[77]  B. D. Rodgers,et al.  Hypophysectomy or Adrenalectomy of Rats with Insulin-Dependent Diabetes Mellitus Partially Restores Their Responsiveness to Growth Hormone , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[78]  G. Chrousos,et al.  Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. , 1999, The Journal of clinical endocrinology and metabolism.

[79]  N. Holbrook,et al.  Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. , 1984, Endocrine reviews.

[80]  D. Wied,et al.  Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats. , 1991, Endocrinology.

[81]  M L Johnson,et al.  Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man. , 1990, The Journal of clinical endocrinology and metabolism.

[82]  M. D. De Bellis,et al.  Urinary catecholamine excretion in sexually abused girls. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

[83]  G. Chrousos,et al.  Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. , 1996, Endocrine reviews.

[84]  M. Dallman,et al.  Corticosteroid inhibition of ACTH secretion. , 1984, Endocrine reviews.

[85]  G. Mazzocchi,et al.  Direct secretagogue effect of corticotropin-releasing factor on the rat adrenal cortex: the involvement of the zona medullaris. , 1992, Endocrinology.

[86]  A. Dobs,et al.  Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. , 1991, The Journal of clinical endocrinology and metabolism.

[87]  R. Stark,et al.  Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. , 1993, The Journal of clinical endocrinology and metabolism.

[88]  K. Catt,et al.  Mechanisms of Action of CRF and Other Regulators of ACTH Release in Pituitary Corticotrophs , 1987, Annals of the New York Academy of Sciences.

[89]  G. Chrousos,et al.  Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. , 1994, The Journal of clinical endocrinology and metabolism.

[90]  D. Papanicolaou,et al.  Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. , 1996, Proceedings of the Association of American Physicians.

[91]  A. Herz,et al.  Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor (in vitro) , 1986, Brain Research.

[92]  K. Rahmouni,et al.  Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins. , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[93]  G. Chrousos,et al.  Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. , 1994, The Journal of clinical endocrinology and metabolism.

[94]  G. Chrousos,et al.  Bone mineral density in women with depression. , 1996, The New England journal of medicine.

[95]  S. Foote,et al.  Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus , 1983, Brain Research.

[96]  G. Chrousos,et al.  The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome. , 1993, The Journal of clinical endocrinology and metabolism.

[97]  W. Vale,et al.  CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.

[98]  M. Demitrack,et al.  Evidence for and Pathophysiologic Implications of Hypothalamic‐Pituitary‐Adrenal Axis Dysregulation in Fibromyalgia and Chronic Fatigue Syndrome , 1998, Annals of the New York Academy of Sciences.

[99]  G. Chrousos,et al.  Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. , 1993, The Journal of clinical investigation.

[100]  D. English,et al.  HAEMODYNAMIC AND NEUROENDOCRINE CONSEQUENCES OF STOPPING SMOKING‐A CONTROLLED STUDY , 1984, Clinical and experimental pharmacology & physiology.

[101]  L. Fisher,et al.  Modulation of central nervous system actions of corticotropin-releasing factor by dynorphin-related peptides , 1989, Brain Research.

[102]  G. Chrousos,et al.  The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. , 1993, Metabolism: clinical and experimental.

[103]  D. Drossman,et al.  Sexual and physical abuse in women with functional or organic gastrointestinal disorders. , 1990, Annals of internal medicine.

[104]  M. Tancer,et al.  Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[105]  A. Iranmanesh,et al.  Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. , 1990, The Journal of clinical endocrinology and metabolism.

[106]  G. Chrousos,et al.  IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. , 2001, The Journal of clinical endocrinology and metabolism.

[107]  Peter J. Munson,et al.  Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[108]  B. Bonaz,et al.  Role of CRF in Stress‐Related Alterations of Gastric and Colonic Motor Function a , 1993, Annals of the New York Academy of Sciences.

[109]  W. Vale,et al.  Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. , 1986, Science.

[110]  F. Goodwin,et al.  Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) , 1988, The New England journal of medicine.